By a GenomeWeb staff reporter

SAN FRANCISCO (GenomeWeb News) – Sequenom officials today said that the firm's Center for Molecular Medicine has billed for more than 1,000 MaterniT21 tests since its launch in mid-October, and Chairman and CEO Harry Hixson said the firm's goal is to bill 25,000 T21 tests in 2012.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.